Response pattern in 844 patients with infiltrating lobular carcinoma (ILC) of the breast after neoadjuvant chemotherapy.
Cristina Pirvulescu
No relevant relationships to disclose
Sibylle Loibl
No relevant relationships to disclose
Gunter Von Minckwitz
No relevant relationships to disclose
Christine Mau
No relevant relationships to disclose
Jens U. Blohmer
Honoraria - Roche; Sanofi
Serban Dan Costa
No relevant relationships to disclose
Holger Eidtmann
No relevant relationships to disclose
Peter A. Fasching
No relevant relationships to disclose
Bernd Gerber
Honoraria - AstraZeneca; GEK; Roche
Michael Untch
No relevant relationships to disclose